Virtu Financial LLC Invests $309,000 in Amedisys, Inc. $AMED

Key Points

• Virtu Financial LLC has acquired 3,331 shares of Amedisys, Inc. during the first quarter, valued at approximately $309,000.
• Institutional investors own 94.36% of Amedisys’ stock, indicating strong confidence in the company's performance.
• Amedisys reported $1.54 earnings per share for the last quarter, surpassing the consensus estimate by $0.15 and showing a year-over-year revenue growth of 5.2%.

Virtu Financial LLC acquired a new stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 3,331 shares of the health services provider's stock, valued at approximately $309,000.

Other institutional investors also recently made changes to their positions in the company. Pentwater Capital Management LP raised its holdings in Amedisys by 178.3% during the 4th quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider's stock valued at $107,132,000 after buying an additional 756,000 shares during the last quarter. AQR Arbitrage LLC raised its holdings in Amedisys by 59.1% during the 4th quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider's stock valued at $42,812,000 after buying an additional 175,311 shares during the last quarter. Toronto Dominion Bank bought a new stake in Amedisys during the 4th quarter valued at $15,801,000. CIBRA Capital Ltd raised its holdings in Amedisys by 359.7% during the 1st quarter. CIBRA Capital Ltd now owns 216,775 shares of the health services provider's stock valued at $20,080,000 after buying an additional 169,616 shares during the last quarter. Finally, Gotham Asset Management LLC raised its holdings in Amedisys by 77.4% during the 4th quarter. Gotham Asset Management LLC now owns 246,918 shares of the health services provider's stock valued at $22,418,000 after buying an additional 107,720 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen lowered shares of Amedisys from a "strong-buy" rating to a "buy" rating in a report on Saturday, May 24th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $100.50.

Amedisys Trading Up 0.0%

NASDAQ AMED traded up $0.03 during trading on Thursday, hitting $101.01. The company had a trading volume of 1,060,057 shares, compared to its average volume of 780,222. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.26. Amedisys, Inc. has a one year low of $82.15 and a one year high of $101.02. The company has a market cap of $3.32 billion, a price-to-earnings ratio of 39.30, a price-to-earnings-growth ratio of 1.34 and a beta of 0.89. The company's fifty day moving average is $98.39 and its 200-day moving average is $94.97.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The health services provider reported $1.54 EPS for the quarter, topping the consensus estimate of $1.39 by $0.15. Amedisys had a net margin of 3.56% and a return on equity of 12.91%. The business had revenue of $621.86 million during the quarter, compared to analyst estimates of $614.61 million. During the same period in the prior year, the business earned $0.98 EPS. The company's revenue for the quarter was up 5.2% on a year-over-year basis. On average, sell-side analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.